Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of preexisting drug-resistance mutations and treatment failure in hepatitis B patients.

PloS one - 1 Jan 2013

Ma Jie, Zhang Yingchun, Chen Xinyue, Jin Yi, Chen Dexi, Wu Yun, Cui Jing, Wang Haitao, Liu Jia, Li Ning, Gao Feng

Abstract excerpt

The role of preexisting minority drug-resistance mutations in treatment failure has not been fully understood in chronic hepatitis B patients. To understand mechanisms of drug resistance, we analyzed drug-resistance mutations in 46 treatment-failure patients and in 29 treatment-naïve patients and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA Mutational Analysis
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Viral

Share to Hepatitis B

Share to Hepatitis B virus

Share to Treatment Failure

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 23935839
DOI: 10.1371/journal.pone.0067606
PMCID: PMC3728369

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23935839-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of preexisting drug-resistance mutations and treatment failure in hepatitis B patients.PMID 23935839Read ↗

Low-level persistence of drug resistance mutations in hepatitis B virus-infected subjects with a past history of Lamivudine treatment.Semantic proximity Read ↗

Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains.Semantic proximity Read ↗

Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010-2016).Semantic proximity Read ↗

Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance.Semantic proximity Read ↗

Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains.Semantic proximity Read ↗

Hepatitis B virus mutation pattern rtA181S+T184I+M204I may contribute to multidrug resistance in clinical practice: Analysis of a large cohort of Chinese patients.Semantic proximity Read ↗

Analysis of low-frequency mutations associated with drug resistance to raltegravir before antiretroviral treatment.Semantic proximity Read ↗

rtM204Q may serve as a novel lamivudine-resistance-associated mutation of hepatitis B virus.Semantic proximity Read ↗

Lamivudine monotherapy in chronic hepatitis B patients from the Indian subcontinent: antiviral resistance mutations and predictive factors of treatment response.Semantic proximity Read ↗

Incidence of natural resistance mutations in naïve chronic hepatitis B patients: a systematic review and meta-analysis.Semantic proximity Read ↗

Management of antiviral drug resistance in chronic hepatitis B.Semantic proximity Read ↗

HBV quasispecies composition in Lamivudine-failed chronic hepatitis B patients and its influence on virological response to Tenofovir-based rescue therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.